Search results
Apr 8, 2024 · Fixed drug eruption (FDE) is a distinctive type of cutaneous drug reaction that characteristically recurs in the same locations upon re-exposure to the offending drug. Acute FDE usually presents with a single or a small number of dusky red or violaceous plaques that resolve leaving postinflammatory hyperpigmentation ( picture 1A-C ).
Sep 1, 2021 · Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by the onset of rash at a fixed location on the body each time a specific medication is ingested. With each recurrence, the eruption can involve additional sites.
- Hannah J Anderson, Jason B Lee
- 10.3390/medicina57090925
- 2021
- Medicina (Kaunas). 2021 Sep; 57(9): 925.
Jan 30, 2020 · A fixed drug eruption (FDE) is a common drug eruption with distinctive morphology and etiology that ranges from antibiotics to cryptic exposure such as to quinine in a gin and tonic. Generalized bullous FDE may resemble SJS/TEN and may prove to be as deadly.
- Shreya Patel, Ann M. John, Marc Zachary Handler, Robert A. Schwartz
- 2020
- What Is Fixed Drug Eruption?
- Who Gets Fixed Drug Eruption?
- What Causes Fixed Drug Eruption?
- What Are The Clinical Features of Fixed Drug Eruption?
- Clinical Variants of Fixed Drug Eruption
- What Are The Complications of Fixed Drug Eruption?
- How Is Fixed Drug Eruption Diagnosed?
- What Is The Differential Diagnosis For Fixed Drug Eruption?
- What Is The Treatment For Fixed Drug Eruption?
- What Is The Outcome For Fixed Drug Eruption?
Fixed drug eruption is a distinctive cutaneous allergic reactionthat characteristically recurs at the same site(s) on re-exposure to the medication or other chemical agent.
Fixed drug eruption affects both sexes, and affects adults more commonly than children. There are some examples of HLA-associations with fixed drug eruptionsdue to specific drugs eg, HLA-A30 with cotrimoxazole-induced fixed drug eruption.
Fixed drug eruption is a delayed type IV hypersensitivity reaction. In the initial phase memory CD8+ T-cells at the dermo-epidermal junction release interferon-gamma when activated by the medication antigen causing epidermal basal layer damage. Recruited T-cells and neutrophils damage melanocytes and keratinocytes. During the resolution phase, derm...
Fixed drug eruption can be categorised by clinical morphology. The most common form is the localised pigmenting type; other presentations include bullous (localised or generalised), mucosal, non-pigmenting, or generalised. Fixed drug eruption typically presents as a single (or small number of) well-defined, round or oval red or violaceous patch or ...
Mucosal fixed drug eruption
1. Involves lips, tongue, hard palate, genitalmucosa 2. Blisters and erosionsare common 3. Can be isolated/localised or may occur with cutaneous lesions 4. Oral mucosal lesions commonly due to cotrimoxazole and naproxen 5. Genital mucosal lesions: glans penis – cotrimoxazole; vulva – NSAIDs.
Non-pigmenting fixed drug eruption
1. Often symmetricallesions 2. Resolves without post-inflammatory hyperpigmentation 3. Associated with piroxicam and pseudoephedrine.
Generalised fixed drug eruption
1. Presents with numerous lesions 2. Lesions may be targetoid resembling erythemamultiforme.
Blisters and erosionsPost-inflammatory hyperpigmentationRecurrenceCross-reaction with other medicationsFixed drug eruption should be considered on history and examination but may be difficult on the first occasion. On subsequent episodes, a detailed history of oral intake in the preceding 24 hours may identify the culprit. Investigations may include: 1. Skin biopsy — shows an interface dermatitis in an early lesion with scattered apoptotic keratinoc...
First episode of single or few lesions — bullous insect bite reaction, bullous pemphigoid and other autoimmunebullous disordersTargetoid lesions — erythema multiformeMultiple bullous lesions — Stevens-Johnson syndrome/toxicepidermal necrolysisOral lesions — herpes simplex, aphthous ulcer, oral autoimmune blistering diseasesDiscontinuation of suspected medicationAvoiding implicated medication indefinitelyTopical steroids/systemic corticosteroidsGeneralised bullous fixed drug eruption requires intensive care or burns unitFixed drug eruption is generally a benignself-resolving eruption that recurs on re-exposure, leaving post-inflammatory hyperpigmentation. Subsequent flares can be more severe. Generalised bullous fixed drug eruption can be life-threatening, and has been reported to have a 20% mortalityrate.
It is defined as a same-site recurrence with exposure to a particular medication. The primary approach and treatment for all types of FDEs are to identify and remove the causative agent, often accomplished by a thorough history of medication and other chemical exposures, and possibly prior episodes.
- Shreya Patel, Ann M. John, Marc Zachary Handler, Robert A. Schwartz
- 2020
Nov 1, 2020 · With the rising use of immunomodulatory and targeted therapeutics in cancer care and the increased incidence in associated reactions to these drugs, the need for accurate identification and treatment of such eruptions has led to the development of the “oncodermatology” subspecialty of dermatology.
The primary treatment for generalized and GBFDE is removal of the causative drug, along with supportive care. Moderate-doseoralcorticosteroidshavenotbeenshown
